Biochemical and Biophysical Research Communications
Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells
Section snippets
Materials and methods
Reagents. TSA, cycloheximide (CHX), mevastatin, farnesylpyrophosphate (FPP), and geranylgeranylpyrophosphate (GGPP) were purchased from Sigma (St. Louis, MO). TSA, mevastatin, and CHX were dissolved in dimethyl sulfoxide (Me2SO) before use. The Clostridium botulinum C3 transferase was purchased from List Biological Laboratories (Campbell, CA) and dissolved in PBS. Mevastatin was chemically activated by alkaline hydrolysis prior to use. Briefly, after 5 mg mevastatin was dissolved in 200 μl Me2SO,
Dual effects of TSA on eNOS mRNA expression
TSA has been demonstrated to down-regulate eNOS expression in endothelial cells after 24 h treatment [6]. While our experiments confirmed this TSA-induced eNOS down-regulation, the true effects of the TSA on eNOS expression appeared to be time- and dose-dependent. Contrary to late inhibition (by 24 h), we observed an induction of eNOS in HUVECs (>2-fold increase) during early stage (as early as 15 min) of the TSA treatment (Fig. 1A). For the dose-dependent effects, we observed that at the low dose
Discussion
In the present study, we demonstrated that inhibition of HDACs by TSA had a dual effect on the eNOS expression in a time- and dose-dependent fashion. Although previous studies demonstrated that TSA down-regulated eNOS by 24 h [6], our study showed that TSA could activate eNOS at the early stage of TSA treatment (by 15 min), and at the low doses (0.1 μg/ml). This up-regulating effect is followed by a time- and dose-dependent repression in the eNOS mRNA expression. We suggest that HDAC inhibition
Acknowledgment
This study was supported by NIH Grant R01-066053. Dr. XL Wang is an AHA Established Investigator.
References (28)
- et al.
Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice
Am. J. Pathol.
(2003) - et al.
The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation
J. Biol. Chem.
(2004) - et al.
Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase
J. Biol. Chem.
(2005) - et al.
Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
J. Biol. Chem.
(1998) - et al.
Characterization of the human endothelial nitric-oxide synthase promoter
J. Biol. Chem.
(1999) - et al.
Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells
J. Biol. Chem.
(2002) - et al.
Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase–mSin3A complex
J. Biol. Chem.
(2002) - et al.
Post-transcriptional regulation of endothelial nitric oxide synthase by an overlapping antisense mRNA transcript
J. Biol. Chem.
(2004) - et al.
Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation
J. Biol. Chem.
(1994) - et al.
c-myc mRNA is down-regulated during myogenic differentiation by accelerated decay that depends on translation of regulatory coding elements
J. Biol. Chem.
(1998)
Targeting of human eNOS promoter to the Hprt locus of mice leads to tissue-restricted transgene expression
Physiol. Genom.
Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel
Arterioscler. Thromb. Vasc. Biol.
Nitric oxide synthases: biochemical and molecular regulation
Curr. Opin. Nephrol. Hypertens.
Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis
Circ. Res.
Cited by (18)
Endothelial cell regulation through epigenetic mechanisms: Depicting parallels and its clinical application within an intra-islet microenvironment
2018, Diabetes Research and Clinical PracticeCitation Excerpt :HDAC inhibitors such as VPA and SAHA have been tested on ECs [130,131]. Though Trichostatin A (TSA), a pan-HDAC inhibitor has been used to treat endothelial stem/progenitor cells [132–135], it is highly toxic and has been ruled out for therapeutics. Lysine specific demethylase 1 (LSD1) is a potential inhibitor of angiogenesis [136].
Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
2011, Artery ResearchCitation Excerpt :However, this latter mechanism is not dependent on Rho signaling.36 TGF-β1 is a 25-kDa peptide that plays an important role in the pathogenesis of atherosclerosis, hypertension and angiogenesis.36 Treatment of bovine aortic ECs with TGF-β1, increased eNOS mRNA in a time- and dose-dependent manner.37
Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene
2008, Journal of Biological ChemistryCitation Excerpt :We generated three constructs as outlined in Fig. 3A. These constructs were built based on the pCMV-2B-eNOS full-length cDNA plasmid generated in our laboratory (18, 19). In Vector 1, the DNA fragment containing the entire intron 4 sequence was inserted.
Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells
2008, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Given that HDACs inhibitors and HMG-CoA inhibitors could be developed to the next generation anti-tumor drugs [1,13,19,35,36], our findings of the synergistic effects of the two classes of inhibitors on apoptosis may have significant clinical implications. Studies have also demonstrated that inhibitors of histone deacetylases could down-regulate expression of endothelial nitric oxide synthase (eNOS) and compromise endothelial cell functions, implying that administration of HDACs inhibitors may have increased cardiovascular risk [25,26]. Basic and clinical studies have shown that statins can significantly improve endothelial functions [37,38]; mevastatin could rescue TSA-induced down-regulation of eNOS [26].
HDAC1: An environmental sensor regulating endothelial function
2022, Cardiovascular ResearchRole of Nitric Oxide and Hydrogen Sulfide in Ischemic Stroke and the Emergent Epigenetic Underpinnings
2019, Molecular Neurobiology